Details for New Drug Application (NDA): 208021
✉ Email this page to a colleague
NDA 208021 describes DICLOFENAC SODIUM, which is a drug marketed by Actavis Mid Atlantic, Alembic, Amneal, Amneal Pharms, Aurolife Pharma Llc, Cipla, Encube, Glenmark Pharms Ltd, Hikma, Padagis Israel, Perrigo Pharma Intl, Taro, Altaire Pharms Inc, Bausch And Lomb, Falcon Pharms, Rising, Rubicon, Sandoz, Sciegen Pharms Inc, Apotex, Epic Pharma Llc, Lupin Ltd, Lupin Pharms, Novel Labs Inc, Pai Holdings Pharm, Twi Pharms, Watson Labs Inc, Zydus Lifesciences, Actavis Elizabeth, Aurobindo Pharma Usa, Carlsbad, Chartwell Rx, Micro Labs, Pliva, Roxane, Teva, Teva Pharms, Unique, Dexcel Ltd, Riconpharma Llc, Vpna, Actavis Labs Fl Inc, Exela Holdings, Yung Shin Pharm, and Zydus Pharms, and is included in sixty-three NDAs. It is available from one hundred and twenty-four suppliers. Additional details are available on the DICLOFENAC SODIUM profile page.
The generic ingredient in DICLOFENAC SODIUM is diclofenac sodium; misoprostol. There are forty-seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the diclofenac sodium; misoprostol profile page.
The generic ingredient in DICLOFENAC SODIUM is diclofenac sodium; misoprostol. There are forty-seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the diclofenac sodium; misoprostol profile page.
Summary for 208021
| Tradename: | DICLOFENAC SODIUM |
| Applicant: | Lupin Pharms |
| Ingredient: | diclofenac sodium |
| Patents: | 0 |
Pharmacology for NDA: 208021
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Physiological Effect | Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 208021
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DICLOFENAC SODIUM | diclofenac sodium | SOLUTION;TOPICAL | 208021 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-537 | 68180-537-01 | 1 BOTTLE, PUMP in 1 CARTON (68180-537-01) / 112 g in 1 BOTTLE, PUMP |
| DICLOFENAC SODIUM | diclofenac sodium | SOLUTION;TOPICAL | 208021 | ANDA | Preferred Pharmaceuticals Inc. | 68788-8743 | 68788-8743-1 | 1 BOTTLE, PUMP in 1 CARTON (68788-8743-1) / 112 g in 1 BOTTLE, PUMP |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
| Approval Date: | Sep 20, 2022 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
